Literature DB >> 18347975

Anti-oligosaccharide antibodies as tools for studying sulfated sialoglycoconjugate ligands for siglecs and selectins.

Reiji Kannagi1, Katsuyuki Ohmori, Naoko Kimura.   

Abstract

Several sulfated sialoglycoconjugates have recently been shown to serve as ligands for selectins and siglecs. For instance, alpha2-->3 sialylated 6-sulfo-Lewis x was found to serve as a ligand for selectins on skin-homing helper memory T cells, and alpha2-->6 sialylated 6-sulfo-LacNAc to be a preferred ligand for CD22/siglec-2 on human naïve B cells. Monoclonal antibodies specific to sulfated sialoglycoconjugates are effective tools to dissect these ligands on minor subsets of human leukocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18347975     DOI: 10.1007/s10719-008-9122-z

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  26 in total

1.  Monoclonal anti-glycosphingolipid antibodies.

Authors:  R Kannagi
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

2.  A novel human Gal-3-O-sulfotransferase: molecular cloning, characterization, and its implications in biosynthesis of (SO(4)-3)Galbeta1-4(Fucalpha1-3)GlcNAc.

Authors:  F M El-Fasakhany; K Uchimura; R Kannagi; T Muramatsu
Journal:  J Biol Chem       Date:  2001-05-16       Impact factor: 5.157

Review 3.  Use of liposomes containing carbohydrates for production of monoclonal antibodies.

Authors:  Reiji Kannagi
Journal:  Methods Mol Biol       Date:  2002

4.  Expression of N-acetylglucosamine 6-O-sulfotransferases (GlcNAc6STs)-1 and -4 in human monocytes: GlcNAc6ST-1 is implicated in the generation of the 6-sulfo N-acetyllactosamine/Lewis x epitope on CD44 and is induced by TNF-alpha.

Authors:  Sie Lung Tjew; Kelly L Brown; Reiji Kannagi; Pauline Johnson
Journal:  Glycobiology       Date:  2005-02-23       Impact factor: 4.313

5.  Expression of sialyl 6-sulfo Lewis X is inversely correlated with conventional sialyl Lewis X expression in human colorectal cancer.

Authors:  M Izawa; K Kumamoto; C Mitsuoka; C Kanamori; A Kanamori; K Ohmori; H Ishida; S Nakamura; K Kurata-Miura; K Sasaki; T Nishi; R Kannagi
Journal:  Cancer Res       Date:  2000-03-01       Impact factor: 12.701

6.  Printed covalent glycan array for ligand profiling of diverse glycan binding proteins.

Authors:  Ola Blixt; Steve Head; Tony Mondala; Christopher Scanlan; Margaret E Huflejt; Richard Alvarez; Marian C Bryan; Fabio Fazio; Daniel Calarese; James Stevens; Nahid Razi; David J Stevens; John J Skehel; Irma van Die; Dennis R Burton; Ian A Wilson; Richard Cummings; Nicolai Bovin; Chi-Huey Wong; James C Paulson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-24       Impact factor: 11.205

7.  Germinal center marker GL7 probes activation-dependent repression of N-glycolylneuraminic acid, a sialic acid species involved in the negative modulation of B-cell activation.

Authors:  Yuko Naito; Hiromu Takematsu; Susumu Koyama; Shizu Miyake; Harumi Yamamoto; Reiko Fujinawa; Manabu Sugai; Yasushi Okuno; Gozoh Tsujimoto; Toshiyuki Yamaji; Yasuhiro Hashimoto; Shigeyoshi Itohara; Toshisuke Kawasaki; Akemi Suzuki; Yasunori Kozutsumi
Journal:  Mol Cell Biol       Date:  2007-02-12       Impact factor: 4.272

8.  Characterization of sialosylated Lewisx as a new tumor-associated antigen.

Authors:  K Fukushima; M Hirota; P I Terasaki; A Wakisaka; H Togashi; D Chia; N Suyama; Y Fukushi; E Nudelman; S Hakomori
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701

9.  Human B-lymphocytes express alpha2-6-sialylated 6-sulfo-N-acetyllactosamine serving as a preferred ligand for CD22/Siglec-2.

Authors:  Naoko Kimura; Katsuyuki Ohmori; Keiko Miyazaki; Mineko Izawa; Yuji Matsuzaki; Yosuke Yasuda; Hiromu Takematsu; Yasunori Kozutsumi; Akihiko Moriyama; Reiji Kannagi
Journal:  J Biol Chem       Date:  2007-08-28       Impact factor: 5.157

10.  Structure of the O-glycans in GlyCAM-1, an endothelial-derived ligand for L-selectin.

Authors:  S Hemmerich; H Leffler; S D Rosen
Journal:  J Biol Chem       Date:  1995-05-19       Impact factor: 5.157

View more
  6 in total

1.  Novel anti-carbohydrate antibodies reveal the cooperative function of sulfated N- and O-glycans in lymphocyte homing.

Authors:  Jotaro Hirakawa; Koichiro Tsuboi; Kaori Sato; Motohiro Kobayashi; Sota Watanabe; Atsushi Takakura; Yasuyuki Imai; Yuki Ito; Minoru Fukuda; Hiroto Kawashima
Journal:  J Biol Chem       Date:  2010-10-07       Impact factor: 5.157

2.  Novel Antibodies Reactive with Sialyl Lewis X in Both Humans and Mice Define Its Critical Role in Leukocyte Trafficking and Contact Hypersensitivity Responses.

Authors:  Ryuji Matsumura; Jotaro Hirakawa; Kaori Sato; Toshiaki Ikeda; Motoe Nagai; Minoru Fukuda; Yasuyuki Imai; Hiroto Kawashima
Journal:  J Biol Chem       Date:  2015-05-05       Impact factor: 5.157

Review 3.  Modifications of glycans: biological significance and therapeutic opportunities.

Authors:  Saddam M Muthana; Christopher T Campbell; Jeffrey C Gildersleeve
Journal:  ACS Chem Biol       Date:  2012-01-11       Impact factor: 5.100

4.  ST3GAL3 mutations impair the development of higher cognitive functions.

Authors:  Hao Hu; Katinka Eggers; Wei Chen; Masoud Garshasbi; M Mahdi Motazacker; Klaus Wrogemann; Kimia Kahrizi; Andreas Tzschach; Masoumeh Hosseini; Ideh Bahman; Tim Hucho; Martina Mühlenhoff; Rita Gerardy-Schahn; Hossein Najmabadi; H Hilger Ropers; Andreas W Kuss
Journal:  Am J Hum Genet       Date:  2011-09-09       Impact factor: 11.025

5.  Directed evolution of lectins with sugar-binding specificity for 6-sulfo-galactose.

Authors:  Dan Hu; Hiroaki Tateno; Atsushi Kuno; Rikio Yabe; Jun Hirabayashi
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

6.  Unmasking of CD22 Co-receptor on Germinal Center B-cells Occurs by Alternative Mechanisms in Mouse and Man.

Authors:  Matthew S Macauley; Norihito Kawasaki; Wenjie Peng; Shui-Hua Wang; Yuan He; Britni M Arlian; Ryan McBride; Reiji Kannagi; Kay-Hooi Khoo; James C Paulson
Journal:  J Biol Chem       Date:  2015-10-27       Impact factor: 5.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.